Outcomes of screening to prevent cancer: think of screening as insurance.
作者信息
Sasieni Peter D
出版信息
BMJ. 2003 Jul 5;327(7405):50; author reply 50. doi: 10.1136/bmj.327.7405.50.
Abstract
摘要
相似文献
1
Outcomes of screening to prevent cancer: think of screening as insurance.
BMJ. 2003 Jul 5;327(7405):50; author reply 50. doi: 10.1136/bmj.327.7405.50.
2
Effect of screening on cervical cancer mortality in England and Wales: analysis of trends with an age period cohort model.
BMJ. 1999 May 8;318(7193):1244-5. doi: 10.1136/bmj.318.7193.1244.
3
Survival from cancer of the uterine cervix in England and Wales up to 2001.
Br J Cancer. 2008 Sep 23;99 Suppl 1(Suppl 1):S63-4. doi: 10.1038/sj.bjc.6604590.
4
Outcomes of screening to prevent cancer: analysis of cumulative incidence of cervical abnormality and modelling of cases and deaths prevented.
BMJ. 2003 Apr 26;326(7395):901. doi: 10.1136/bmj.326.7395.901.
5
Has screening for cervical cancer been successful?
Br J Obstet Gynaecol. 1997 Aug;104(8):876-8. doi: 10.1111/j.1471-0528.1997.tb14343.x.
6
Harms and benefits of screening to prevent cervical cancer.
Lancet. 2004;364(9444):1483-4; author reply 1485-6. doi: 10.1016/S0140-6736(04)17260-7.
7
Harms and benefits of screening to prevent cervical cancer.
Lancet. 2004;364(9444):1483; author reply 1485-6. doi: 10.1016/S0140-6736(04)17259-0.
8
Trends in mortality from uterine cancer in relation to mass screening.
Acta Cytol. 1977 Jan-Feb;21(1):5-9.
9
The management of a cervical screening programme: a statement (October 1985). The ICRF Coordinating Committee on Cervical Screening.
Community Med. 1986 Aug;8(3):179-84.
10
Effect of screening on cervical cancer mortality in England and Wales. Interactive effects and causation must be considered.
BMJ. 1999 Aug 28;319(7209):581. doi: 10.1136/bmj.319.7209.581.
引用本文的文献
1
Awareness and uptake of the Pap smear among market women in Lagos, Nigeria.
J Public Health Afr. 2011 Feb 14;2(1):e14. doi: 10.4081/jphia.2011.e14. eCollection 2011 Mar 1.
本文引用的文献
1
Outcomes of screening to prevent cancer: analysis of cumulative incidence of cervical abnormality and modelling of cases and deaths prevented.
BMJ. 2003 Apr 26;326(7395):901. doi: 10.1136/bmj.326.7395.901.
2
Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. The National Co-ordinating Network for Cervical Screening Working Group.
Br J Cancer. 1996 Apr;73(8):1001-5. doi: 10.1038/bjc.1996.196.
3
Screening for squamous cervical cancer: duration of low risk after negative results of cervical cytology and its implication for screening policies. IARC Working Group on evaluation of cervical cancer screening programmes.
Br Med J (Clin Res Ed). 1986 Sep 13;293(6548):659-64. doi: 10.1136/bmj.293.6548.659.
Zotero 插件